CLINICAL_TRIALS
trial_result
· 2024-03-22
Clinical Trial Update: Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease [Phase 1]
Summary
Phase 1 pharmacokinetic study of intranasal dexmedetomidine in pediatric patients with congenital heart disease has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Hospital of Philadelphia | Conditions: Dexmedetomidine, Congenital Heart Disease | Phase 1 | Status: TERMINATED | Results posted: 2024-03-22